-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q3 2024.
- Lifecore Biomedical, Inc. \De\ Net Cash Provided by (Used in) Financing Activities for the quarter ending August 25, 2024 was $1.09M, a 62.7% decline year-over-year.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7.51M, a 81.1% decline from 2022.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $39.7M.
- Lifecore Biomedical, Inc. \De\ annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$57M, a 1568% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)